Retroviridae Proteins, Oncogenic
"Retroviridae Proteins, Oncogenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Retroviral proteins that have the ability to transform cells. They can induce sarcomas, leukemias, lymphomas, and mammary carcinomas. Not all retroviral proteins are oncogenic.
| Descriptor ID |
D015682
|
| MeSH Number(s) |
D12.776.624.664.520.750 D12.776.964.700.750 D12.776.964.775.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Retroviridae Proteins, Oncogenic".
Below are MeSH descriptors whose meaning is more specific than "Retroviridae Proteins, Oncogenic".
This graph shows the total number of publications written about "Retroviridae Proteins, Oncogenic" by people in this website by year, and whether "Retroviridae Proteins, Oncogenic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 2 | 1 | 3 |
| 2000 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Retroviridae Proteins, Oncogenic" by people in Profiles.
-
Liu A, Prendergast GC. Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitors. FEBS Lett. 2000 Sep 22; 481(3):205-8.
-
Majewski M, Nieborowska-Skorska M, Salomoni P, Slupianek A, Reiss K, Trotta R, Calabretta B, Skorski T. Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. Cancer Res. 1999 Jun 15; 59(12):2815-9.
-
Prendergast GC. Myc and Myb: are the veils beginning to lift? Oncogene. 1999 May 13; 18(19):2914-5.
-
Valentinis B, Morrione A, Peruzzi F, Prisco M, Reiss K, Baserga R. Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion. Oncogene. 1999 Mar 11; 18(10):1827-36.
-
Westwick JK, Lee RJ, Lambert QT, Symons M, Pestell RG, Der CJ, Whitehead IP. Transforming potential of Dbl family proteins correlates with transcription from the cyclin D1 promoter but not with activation of Jun NH2-terminal kinase, p38/Mpk2, serum response factor, or c-Jun. J Biol Chem. 1998 Jul 03; 273(27):16739-47.
-
Kubota S, Pomerantz RJ. A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins. Oncogene. 1998 Apr 09; 16(14):1851-61.
-
Kubota S, Hatanaka M, Pomerantz RJ. Nucleo-cytoplasmic redistribution of the HTLV-I Rex protein: alterations by coexpression of the HTLV-I p21x protein. Virology. 1996 Jun 15; 220(2):502-7.
-
Feinman R, Qiu WQ, Pearse RN, Nikolajczyk BS, Sen R, Sheffery M, Ravetch JV. PU.1 and an HLH family member contribute to the myeloid-specific transcription of the Fc gamma RIIIA promoter. EMBO J. 1994 Aug 15; 13(16):3852-60.
-
Prendergast GC, Davide JP, deSolms SJ, Giuliani EA, Graham SL, Gibbs JB, Oliff A, Kohl NE. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol Cell Biol. 1994 Jun; 14(6):4193-202.
-
Sala A, Calabretta B. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc Natl Acad Sci U S A. 1992 Nov 01; 89(21):10415-9.